Bayer AG
BAYN: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€91.00 | Zthwbwf | Ffmcp |
Bayer: Lowering FVE and Moat Rating Based on Slowing Innovation and Litigation Concerns
We are lowering Bayer’s moat rating to Narrow from Wide and cutting the firm’s fair value to EUR 75 ($20.50 on the ADR) from EUR 83 ($22.50) due to a slowing of innovation within the firm and continuing glyphosate legal issues. We are increasing Bayer’s Uncertainty Rating to High from Medium based on the firm’s high debt levels and less clarity around glyphosate legal issues.